Tau and 14-3-3 in glial cytoplasmic inclusions of multiple system atrophy

被引:36
作者
Giasson, BI
Mabon, ME
Duda, JE
Montine, TJ
Robertson, D
Hurtig, HI
Lee, VMY
Trojanowski, JQ
机构
[1] Univ Penn, Sch Med, Dept Pathol & Lab Med, Ctr Neurodegenerat Dis Res, Philadelphia, PA 19104 USA
[2] Vet Adm Hosp, Parkinsons Dis Res Educ & Clin Ctr, Philadelphia, PA USA
[3] Vanderbilt Univ, Dept Pathol, Nashville, TN 37232 USA
[4] Univ Penn, Sch Med, Dept Neurol, Philadelphia, PA 19104 USA
[5] Univ Penn, Sch Med, Inst Aging, Philadelphia, PA 19104 USA
关键词
14-3-3; proteins; alpha-synuclein; glial cytoplasmic inclusions; multiple system atrophy; tau;
D O I
10.1007/s00401-003-0726-x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Multiple system atrophy (MSA) is a neurodegenerative disease characterized by the presence of glial cytoplasmic inclusions (GCIs), which are comprised of fibrils of the protein alpha-synuclein (alpha-syn). Increasing evidence indicate that the formation of these lesions leads to cellular dysfunction and degeneration. The events that result in the fort-nation of GCIs remain poorly understood. It is possible that changes in the cytoplasmic milieu, perhaps the aberrant expression of alpha-syn-interacting proteins, can promote the polymerization of alpha-syn. The presence of the microtubule-binding protein, tau, in GCIs has been reported in some studies, but these findings have not been consistent, and these studies were performed prior to the availability of the more sensitive methods of detecting GCIs using anti-alpha-syn antibodies. Recently, 14-3-3 proteins, putative alpha-syn-interacting partners, have been reported in Lewy bodies, which also are pathological inclusions comprised of alpha-syn. In this study the presence of tau and 14-3-3 proteins in GCIs of 21 patients with MSA was investigated. For the majority of cases, tau and 14-3-3 proteins were detected only in a subset of GCIs. In some cases none of the GCIs contained 14-3-3 or tau. When present in GCIs, tau was in a hypophosphorylated state as demonstrated with phosphorylation-specific antibodies. alpha-syn fibrillogenesis without 14-3-3 or tau appears to be sufficient for GCI formation, although it is possible that the accumulation of multi-functional proteins, like 14-3-3, in GCIs contribute to the disruption of cellular homeostasis.
引用
收藏
页码:243 / 250
页数:8
相关论文
共 79 条
[1]  
ABE H, 1992, ACTA NEUROPATHOL, V84, P273
[2]   IMMUNOCYTOCHEMICAL AND ULTRASTRUCTURAL STUDIES OF NEURONAL AND OLIGODENDROGLIAL CYTOPLASMIC INCLUSIONS IN MULTIPLE SYSTEM ATROPHY .1. NEURONAL CYTOPLASMIC INCLUSIONS [J].
ARIMA, K ;
MURAYAMA, S ;
MUKOYAMA, M ;
INOSE, T .
ACTA NEUROPATHOLOGICA, 1992, 83 (05) :453-460
[3]   NACP/α-synuclein immunoreactivity in fibrillary components of neuronal and oligodendroglial cytoplasmic inclusions in the pontine nuclei in multiple system atrophy [J].
Arima, K ;
Uéda, K ;
Sunohara, N ;
Arakawa, K ;
Hirai, S ;
Nakamura, M ;
Tonozuka-Uehara, H ;
Kawai, M .
ACTA NEUROPATHOLOGICA, 1998, 96 (05) :439-444
[4]   Genetic analysis of families with Parkinson disease that carry the Ala53Thr mutation in the gene encoding α-synuclein [J].
Athanassiadou, A ;
Voutsinas, G ;
Psiouri, L ;
Leroy, E ;
Polymeropoulos, MH ;
Ilias, A ;
Maniatis, GM ;
Papapetropoulos, T .
AMERICAN JOURNAL OF HUMAN GENETICS, 1999, 65 (02) :555-558
[5]  
Baba M, 1998, AM J PATHOL, V152, P879
[6]  
BINDER LI, 1985, J CELL BIOL, V101, P1371, DOI 10.1083/jcb.101.4.1371
[7]   HUMAN 14-3-3 PROTEIN - RADIOIMMUNOASSAY, TISSUE DISTRIBUTION, AND CEREBROSPINAL-FLUID LEVELS IN PATIENTS WITH NEUROLOGICAL DISORDERS [J].
BOSTON, PF ;
JACKSON, P ;
THOMPSON, RJ .
JOURNAL OF NEUROCHEMISTRY, 1982, 38 (05) :1475-1482
[8]   Tau protein in the glial cytoplasmic inclusions of multiple system atrophy can be distinguished from abnormal tau in Alzheimer's disease [J].
Cairns, NJ ;
Atkinson, PF ;
Hanger, DP ;
Anderton, BH ;
Daniel, SE ;
Lantos, PL .
NEUROSCIENCE LETTERS, 1997, 230 (01) :49-52
[9]  
Chin SSM, 1996, J NEUROPATH EXP NEUR, V55, P499
[10]   Accelerated in vitro fibril formation by a mutant α-synuclein linked to early-onset Parkinson disease [J].
Conway, KA ;
Harper, JD ;
Lansbury, PT .
NATURE MEDICINE, 1998, 4 (11) :1318-1320